Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,007 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

NCT00354120

Conditions
Acute Myeloblastic Leukemia, Anemia, Anemia, Refractory, +28 more
Locations
  • Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy
  • Divisione Ematologia - Ospedale "SS. Antonio, Biagio e Cesare Arrigo" Alessandria, Italy
  • Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy
  • Divisione di Ematologia - Ospedali Riuniti Bergamo Bergamo, Italy
View all 22 locations
View Trial Details
Completed

Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

NCT02345850

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +17 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 28 locations
View Trial Details
Completed

Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)

NCT02016781

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 37 locations
View Trial Details
Completed

The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)

NCT02269267

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Helen Diller Family Comprehensive Cancer Center University of California San Francisco, California, United States
  • Moffit Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Chicago Chicago, Illinois, United States
View all 16 locations
View Trial Details
Completed

An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)

NCT02775903

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 103 locations
View Trial Details
Completed

Agrylin Drug Use-Result Survey

NCT03625895

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Gamagori-city Gamagōri, Aichi-ken, Japan
  • Handa City Handa, Aichi-ken, Japan
  • Hekinan-city Hekinan, Aichi-ken, Japan
  • Ichinomiya-city Ichinomiya, Aichi-ken, Japan
View all 488 locations
View Trial Details
Completed

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant

NCT00796068

Conditions
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +25 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions